Use of 10-[(3R)-1azabicyclo[2.2.2]oct-3-ylmethyl]-10Hphenothiazine for the preparation of a drug having a selective inhibition of muscarinic M1, M2 and M3 receptors

Details for Australian Patent Application No. 2007341274 (hide)

Owner Pierre Fabre Medicament

Inventors Przybylski, Christophe; Clerc, Thierry; Tisne-Versailles, Jacky

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007341274

PCT Pub. Number WO2008/080924

Priority 0656002 28.12.06 FR

Filing date 26 December 2007

Wipo publication date 10 July 2008

Acceptance publication date 20 September 2012

International Classifications

A61K 31/5415 - ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam

A61P 13/00 Drugs for disorders of the urinary system

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/080924 Priority application(s): WO2008/080924

20 September 2012 Application Accepted

  Published as AU-B-2007341274

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007341280-Method and materials for triggered release of a biological sample

2007341263-Composition for structural adhesive